Fluvoxamine and COVID-19: Here’s How the OCD Drug Might Help Prevent COVID-19 Infections From Getting Worse

There is no patent on this drug either, they want to re-purpose the drug to fight covid-19 and it's cheap in price too!

The COVID-19 vaccine rollout has been the main focus of attention over the last few months—more than 90 million doses have been administered since distribution began on December 14, at a rate of more than 2.2 million shots per day. But at the same time, scientists have continued to work hard to find treatments for people who get infected.

One of them, the generic drug fluvoxamine, has shown huge potential. Developed 40 years ago as an antidepressant, fluvoxamine—sometimes known as Luvox—has been used mainly to treat obsessive-compulsive disorder (OCD), per the National Alliance on Mental Illness (NAMI). But now, researchers are taking a closer look at how the medication could be an important treatment to prevent patients who test positive for COVID-19 from getting seriously ill with the infection.

David Seftel, MD, a physician in Berkeley, California, opted to offer a 15-day prescription to his own COVID-19 patients, who fell victim to an outbreak in the Golden Gate Fields race track community. (FYI: His decision to use a prescription drug off-label is an accepted medical practice, provided the patient consents. "Off-label" simply means it hasn't been approved by the FDA for that particular condition.

https://www.health.com/condition/inf...amine-covid-19